Generex (GNBT) Launches $250mln Lawsuit Against (TSMC)

Generex Biotechnology Corp. (GNBT) has announced that has commenced legal proceedings against (TSCM) and Adam Feuerstein in the Supreme Court of the State of New York seeking $250 million in damages for business defamation, product disparagement, and injurious falsehood.

The claims arise out of articles authored by Feuerstein and published on website on March 19 and March 26, 2010.

According to Generex, “the articles disseminate numerous defamatory statements about the co, its management, and its flagship product, Generex Oral-lyn, and that the articles put forward several ostensible statements of fact that are, in truth, misleading or outright misstatements made with malicious intent or with a reckless disregard for the truth.”

Full Generex press release available here »

Disclaimer: This page contains affiliate links. If you choose to make a purchase after clicking a link, we may receive a commission at no additional cost to you. Thank you for your support!

Be the first to comment

Leave a Reply

Your email address will not be published.


This site uses Akismet to reduce spam. Learn how your comment data is processed.